Stem Cell-Derived Retinal Pigment Epithelial Cells

Patent No. EP2554661 (titled "Stem Cell-Derived Retinal Pigment Epithelial Cells") was filed by Hadasit Medical Research Services on Apr 27, 2008. The application was issued on Feb 21, 2018.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
PFIZER LIMTEDAug 12, 2015LAVOIX
JAMES POOLENov 19, 2014GOODFELLOW

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2554661

HADASIT MEDICAL RESEARCH SERVICES
Application Number
EP12181140A
Filing Date
Apr 27, 2008
Status
Patent Maintained As Amended
Jan 19, 2018
Publication Date
Feb 21, 2018